logo
welcome
Reuters

Reuters

Musk's Neuralink says second trial implant went well, no thread retraction issue

Reuters
Summary
Nutrition label

80% Informative

Elon Musk's brain technology startup Neuralink said its implant is working well in a second trial patient.

The patient, identified as Alex , did not face issues of "thread retraction", unlike Noland Arbaugh , Neuralink 's first patient.

Neuralink is in the process of testing its device, which is intended to help people with spinal cord injuries.

VR Score

89

Informative language

93

Neutral language

87

Article tone

semi-formal

Language

English

Language complexity

57

Offensive language

possibly offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links